Oura's $625 million Counsel Health deal puts a ring maker in the triage business

Oura is paying $625 million in cash for Counsel Health, a company that pairs a medical chatbot with board-certified physicians who can join the same conversation within minutes. The smart ring maker announced the definitive agreement on November 10, and TechCrunch's Aisha Malik noted that Counsel's service had already been running inside the Oura app since June.

For business buyers, the bigger shift sits in a different set of contracts. Counsel also sells to health plans, health systems, employers and consumer health companies, and Oura says it will keep doing so after the deal closes. For a benefits director or plan executive who buys after-hours triage or virtual primary care, one vendor on the shortlist is about to belong to a wearable company with more than six million members.

Counsel founder and CEO Muthu Alagappan becomes Oura's chief clinical AI officer, and Bloomberg reported that Counsel's roughly 70 employees are joining with him.

How Counsel's chat hands off to a doctor

The engine underneath is what Counsel calls a clinical AI harness. In Oura's announcement, carried on Business Wire, the harness is described as calling specialized agents for separate jobs: taking a medical history, retrieving clinical guidelines, reviewing records and detecting emergencies. Counsel says each agent is evaluated for performance, safety and quality, and that its physicians' feedback is used to improve them.

A member starts in one of two places: an insight from the Oura app, or a direct chat with Counsel's AI. The AI pulls from connected medical records, earlier conversations, evidence-based guidelines and continuous biometric data. At any point the member can add a Counsel physician, who can diagnose, prescribe and refer. Behind the scenes, those physicians work in a proprietary interface Counsel calls the Clinician Cockpit, which condenses the patient's record and long-term health trends into suggestions for the doctor.

The design puts the AI in charge of gathering context and the physician in charge of decisions. That split is the part a buyer should test hardest. Emergency detection is the agent that decides whether a chat should stop being a chat, so it is the agent whose evaluation results matter most to anyone thinking of replacing a nurse line with this model.

A ring company inside the triage budget

Counsel's own company description is blunt about its target. It says it replaces legacy access points such as nurse triage lines and telehealth, resolves most member needs within minutes, and helps partners cut unnecessary downstream care and costs. Those are company claims, and the announcement attaches no figures to them. Still, they define the comparison Counsel invites.

For $625 million in cash, a smart ring company now owns a service pitched to health plans as a replacement for the nurse triage line.

There is one public price to work from. Counsel's website says users can start with a free conversation with Counsel AI and add a doctor to the same conversation for $29 when they need one. Enterprise contracts are priced separately, but $29 for a physician touch is a useful benchmark for a benefits team comparing per-encounter virtual care costs. Dealroom also reported that the two companies had extended their tie-up into a Centers for Medicare and Medicaid Services program for chronic-care management.

Oura is treating the enterprise channel as part of the purchase case. Executive chairman David Shuman said in the announcement that Counsel's enterprise partners open the door to millions of people beyond Oura's member base. That suggests existing Counsel customers are a growth channel the new owner wants to expand. For plans whose members already wear Oura rings, continuous biometric context could reach the encounter. Oura's 2026 Annual Healthcare Report, aimed at payers and health plans, says members wear Oura Ring an average of 23.5 hours a day. For plans whose members don't, the product is still the AI-plus-physician model, just without the ring data.

Oura paired the deal with preliminary, unaudited results that show the financial footing of Counsel's new parent.

Satisfaction scores, outcomes still pending

The early evidence is encouraging and narrow. Among members who use Counsel, more than 90% of those surveyed said their Oura data helped them get better care, and members who saw a Counsel physician rated the experience 4.6 out of 5. Both figures are self-reported, and the announcement does not give the number of people surveyed. They measure satisfaction. They don't measure fewer ER visits or better-controlled blood pressure.

Dealroom made the same point from the deal side: Oura still has to show that wearable-informed AI care improves outcomes and can scale under clinical and reimbursement rules. The price adds to the stakes. Counsel raised a $25 million Series A led by Andreessen Horowitz and GV a year ago, and PitchBook estimates its total funding at $36 million, so Oura is paying about 17 times what Counsel raised, by Dealroom's arithmetic.

Oura isn't alone in this direction. TechCrunch notes that RingConn and Ultrahuman are competing hard in smart rings, and Dealroom points to WHOOP adding lab testing, clinician connections and AI guidance. Several device makers moving toward care delivery indicates that plan and employer buyers may see more virtual care offers with a wearable attached. That would matter most to organizations that already subsidize fitness wearables for members or staff.

Questions to settle before the close

Plans, health systems and employers already working with Counsel, or evaluating it, have a short window to get answers on the record while the contract terms are still those of an independent vendor.

1. Which of Counsel's AI agents, starting with emergency detection, have published evaluation results, and how often do physician corrections change them?
2. For members who own Oura rings, will biometric data enter encounters by default or by opt-in, and what reaches the partner's own records?
3. How do the planned preventive, acute and chronic care tracks, including reproductive health, aging and cardiometabolic care, overlap with programs the partner already pays for?

The timing is less settled than the price. Oura's announcement says the deal should close before the end of the calendar year, subject to customary conditions and purchase price adjustments, while TechCrunch reported the expected close as before the end of 2027. If Oura's date holds, Counsel's enterprise customers could find their vendor under Oura ownership before the end of 2026.